Why Shares of Repligen Soared in October
Shares of bioprocessing technology company Repligen (NASDAQ: RGEN) soared 12.9% in October according to data provided by S&P Global Market Intelligence. The move comes in a remarkable year for the company as its stock has more than doubled so far in 2020.
The reason? Simply put, the COVID-19 pandemic has added more fire to an already hot market. Repligen is a small player in a bioprocessing market dominated by far larger companies such as Danaher (NYSE: DHR), MilliporeSigma, and Thermo Fisher. Nevertheless, Repligen is a leader in niche markets such as pre-packed chromatography and filtration, making it a great growth stock for in-the-know investors.
Image source: Getty Images.
Source Fool.com
